Literature DB >> 16532107

The treatment of masseter hypertrophy with botulinum toxin type A.

Hazem T Al-Ahmad1, Mansour A Al-Qudah.   

Abstract

Masseter hypertrophy is a benign condition with variable causative factors, such as bruxism, temporomandibular disorders, malocclusion and others, but has an unclear etiology in the majority of cases. Surgical masseteric resection was the conventional method of treatment for the asymmetric swellings over the ramus and angle of the mandible on one or both sides, in addition to the generally unsuccessful treatments of occlusal adjustment, splint therapy, tranquilizers or others. An effective alternative was the local injection of very small doses of botulinum toxin type A into the masseter. The toxin binds permanently to the motor end plate preventing acetylcholine release causing pre-synaptic neuromuscular blockade, the muscle can be selectively weakened and local paralysis is followed by atrophy of the muscle. Four cases with their follow-up are reported. This technique provided a predictable and conservative method of treatment for this type of facial asymmetry.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16532107

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  8 in total

Review 1.  BOTOX: Broadening the Horizon of Dentistry.

Authors:  Pranav Nayyar; Pravin Kumar; Pallavi Vashisht Nayyar; Anshdeep Singh
Journal:  J Clin Diagn Res       Date:  2014-12-05

2.  Histological changes and changes in the myosin mRNA content of the porcine masticatory muscles after masseter treatment with botulinum toxin A.

Authors:  T Gedrange; T Gredes; A Spassov; R Mai; D U Kuhn; M Dominiak; C Kunert-Keil
Journal:  Clin Oral Investig       Date:  2012-06-15       Impact factor: 3.573

3.  Idiopathic masseter muscle hypertrophy.

Authors:  Biruktawit Kebede; Shimalis Megersa
Journal:  Ethiop J Health Sci       Date:  2011-11

4.  Surgical management of masseteric hypertrophy and mandibular retrognathism.

Authors:  Sourav Singh; D M Shivamurthy; Gunjan Agrawal; Don Varghese
Journal:  Natl J Maxillofac Surg       Date:  2011-01

Review 5.  Botulinum toxin: The Midas touch.

Authors:  P S Shilpa; Rachna Kaul; Nishat Sultana; Suraksha Bhat
Journal:  J Nat Sci Biol Med       Date:  2014-01

6.  Idiopathic masseter muscle hypertrophy: a case report.

Authors:  Joana Jorge Antunes; Susana Assunção Almeida; Ricardo Miguel Patrício de Carvalho Monteiro; Ana Mafalda Martins
Journal:  Einstein (Sao Paulo)       Date:  2019-03-07

7.  Management of unilateral masseter hypertrophy and hypertrophic scar-a case report.

Authors:  Naresh Shetty; Rajanikanth K Malaviya; M K Gupta
Journal:  Case Rep Dent       Date:  2012-07-10

8.  A comparative study of the efficacy and safety of radiofrequency ablation and botulinum toxin A in treating masseteric hypertrophy.

Authors:  Jin-Long Huang; Gang Chen; Xiao-Dong Chen; Bing-Rong Zhou; Dan Luo
Journal:  Exp Ther Med       Date:  2014-02-17       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.